During a recent interview, Dwarkesh Patel and the CEO of Anthropic, Dario Amodei, discussed whether clinical trials will remain a meaningful bottleneck for drug development in the age of AI. Patel said that “most clinical trials fail because the drug does not work.” In response, Amodei speculated that as AI models get better at designing drugs, “clinical trials will be much faster … let’s say, they will take one year.”This is a commonly voiced sentiment, but flawed. The truth is that the most si...